Catalyst Wire Dossier Catalyst Wire Dossier

PRV-015

PRV-015 · Provention Bio (a Sanofi Company)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRV-015, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: PRV-015 in Gluten-free Diet Non-responsive Celiac Disease [Phase 2]

See pricing